Human cardiac prediction from data you already have.
FilamenTech develops multiscale mechanistic simulation workflows that help drug-development teams translate assay, tissue, animal, mutation, and structural data into human-relevant cardiac and muscle predictions.
Boston • Belgrade
Start with a focused pilot.
Evaluate mutation effects, drug responses, or translational hypotheses using mechanistic simulation workflows tailored to your program.
© 2026 FilamenTech. All rights reserved.
Created by Starter studio.